Back to search

Article

Interaction Between the Gut Microbiome, Genetic and Clinical Risk Factors for Metabolic Dysfunction‐Associated Steatotic Liver Disease (MASLD) in Patients with Type 2 Diabetes Mellitus from Different Geographical Regions of Argentina

2025-11-18

Abstract excerpt

<h4>Background: </h4> Local specific biomarkers for MASLD risk stratification are urgently needed in Argentina. <h4>Aim:</h4> To characterized the interaction of gut microbiome signatures, genetic and clinical risk factors for MASLD in diabetics from different regions of Argentina. Material Methods: We recruited 214 diabetics from different regions. Anthropometric, clinical, and lifestyle data were obtained from a...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
e28172aa-f442-5441-805a-0d3c1057d450
DOI
10.20944/preprints202511.1291.v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Interaction Between the Gut Microbiome, Genetic and Clinical Risk Factors for Metabolic Dysfunction‐Associated Steatotic Liver Disease (MASLD) in Patients with Type 2 Diabetes Mellitus from Different Geographical Regions of ArgentinaDOI 10.20944/preprints202511.1291.v1
Epidemiological Study on the Interaction between the PNPLA3 (rs738409) and Gut Microbiota in Metabolic Dysfunction-Associated Steatotic Liver Disease.Semantic proximity
The Gut Microbiota and Diabetes: Research, Translation, and Clinical Applications—2023 Diabetes , Diabetes Care , and Diabetologia Expert ForumSemantic proximity
The Gut Microbiota and Diabetes: Research, Translation, and Clinical Applications—2023 Diabetes, Diabetes Care, and Diabetologia Expert ForumSemantic proximity
Plasma and stool metabolomics to identify microbiota derived-biomarkers of metabolic dysfunction-associated fatty liver disease: effect of PNPLA3 genotype.Semantic proximity
Microbial Dysbiosis Linked to Metabolic Dysfunction-Associated Fatty Liver Disease in Asians: Prevotella copri Promotes Lipopolysaccharide Biosynthesis and Network Instability in the Prevotella EnterotypeSemantic proximity
The role of gut microbiota in the occurrence and progression of non-alcoholic fatty liver diseaseSemantic proximity
Fecal Microbiota Composition, Their Interactions, and Metagenome Function in US Adults with Type 2 Diabetes According to EnterotypesSemantic proximity
Dissecting genome-wide studies for microbiome-related metabolic diseases.Semantic proximity
Plasma and stool metabolomic biomarkers of non-alcoholic fatty liver disease in ArgentinaSemantic proximity
Oxidative Balance Score, Genetic Predictors of the Gut Microbiome, and the Risk of Metabolic-Associated Fatty Liver Disease: A Cohort Study.Semantic proximity
Liver microbiome composition associates with histological severity and PNPLA3 genotype in metabolic dysfunction-associated steatotic liver diseaseSemantic proximity
Dietary fiber intake, genetic predisposition of gut microbiota, and the risk of metabolic dysfunction-associated steatotic liver diseaseSemantic proximity
Select a neighboring publication to make it the new centre.